Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2. Oda Y, Kumagai Y, Kanai M, Iwama Y, et al. Lancet Infect Dis 2024 Feb 1:S1473-3099(24)00060.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oda Y, Kumagai Y, Kanai M, Iwama Y, et al. Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2. Lancet Infect Dis 2024 Feb 1:S1473-3099(24)00060.
PMID: 38310906